| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Clark Eliana | EVP, Chief Technical Officer | C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE | /s/ James Basta, attorney-in-fact | 03 Jul 2025 | 0001914448 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTLA | Common Stock | Sale | $10,036 | -1,022 | -1.1% | $9.82 | 95,369 | 01 Jul 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025. |